Comparison of noncontrast MRI magnetization transfer and T2‐Weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn's disease animal model by Dillman, Jonathan R. et al.
ORIGINAL RESEARCH
Comparison of Noncontrast MRI
Magnetization Transfer and T2-Weighted
Signal Intensity Ratios for Detection of
Bowel Wall Fibrosis in a Crohn’s Disease
Animal Model
Jonathan R. Dillman, MD,1* Scott D. Swanson, PhD,2 Laura A. Johnson, BS,3
David S. Moons, MD, PhD,4 Jeremy Adler, MD, MS,5 Ryan W. Stidham, MD,3
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Purpose: To compare the abilities of magnetization transfer magnetic resonance imaging (MT-MRI) and T2-weighted
signal intensity (T2WSI) ratios to detect intestinal fibrosis in a Crohn’s disease animal model.
Materials and Methods: Ten rats ("Group 1") received one trinitrobenzenesulfonic acid enema to induce acute colonic
inflammation, while 10 additional animals ("Group 2") received multiple enemas to induce colonic inflammation and
fibrosis. Gradient recalled-echo MT-MRI (5 and 10 kHz off-resonance) and T2-weighted spin-echo imaging were per-
formed 2 days after the last enema. MT ratios (MTR) and T2WSI ratios were calculated in the area of greatest colonic
thickening. Bowel wall MTR, bowel wall MTR normalized to paraspinous muscle MTR ("normalized MTR"), and T2WSI
ratios were compared between animal groups using Student’s t-test.
Results: At 10 kHz off-resonance, mean bowel wall MTR for Group 1 was 24.863.1% vs. 30.363.2% for Group 2
(P50.001). Mean normalized MTR was 0.456 0.05 for Group 1 and 0.586 0.08 for Group 2 (P5 0.0003). At 5 kHz off-
resonance, mean bowel wall MTR for Group 1 was 34.765.2% vs. 40.363.6% for Group 2 (P50.015). Mean normal-
ized MTR was 0.536 0.08 for Group 1 and 0.6460.07 for Group 2 (P5 0.003). Mean T2WSI ratio was 5.326 0.98 for
Group 1 and 3.016 0.66 for group 2 (P<0.0001). Mean T2WSI ratio/MTR (10 kHz off-resonance) was 12.066 2.70 for
Group 1 and 5.226 1.29 for Group 2 (P<0.0001), with an ROC c-statistic of 0.98.
Conclusion: MTR and T2WSI ratios detect bowel wall fibrosis in a Crohn’s disease animal model.
J. MAGN. RESON. IMAGING 2015;42:801–810.
Crohn’s disease (CD) is a segmental granulomatousinflammatory bowel disease that affects about 600,000
children and adults in the United States, is associated with
substantial morbidity and healthcare costs, and is commonly
characterized by recurring periods of exacerbation and remis-
sion.1–3 Over time, repeated bowel wall injury due to acute
and chronic inflammation and related attempts at healing
can unpredictably result in the deposition of fibrous tissue
(scar).4–7 In some CD patients, this bowel wall fibrosis may
cause areas of intestinal narrowing (strictures) that are refrac-
tory to currently available medical therapies, thus requiring
surgical resection, surgical stricturoplasty, or endoscopic
dilatation.8,9
At histopathology, intestinal strictures in CD can be
predominantly inflammatory, predominantly fibrotic, or due
to a mixture of both inflammation and fibrosis.10 The
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ability to reliably, noninvasively characterize strictures could
directly impact CD patient management, as predominantly
inflammatory strictures commonly respond to medical
immunosuppressive and antiinflammatory therapies, whereas
strictures containing substantial fibrosis (either mixed or
predominantly fibrotic) are often managed using surgical or
FIGURE 1: A,B: Axial MT-MRI images through the distal colon (arrows) without and with 10 kHz off-resonance pulse in a Group 1
animal (purely inflamed bowel). C: Axial parametric map displays calculated MT ratios (MTR from 0 to 100%) for the bowel wall
and paraspinous muscles. Muscle and bowel wall show magnetization transfer (MT) effect (skeletal muscle greater than bowel),
while fat and fluid in the urinary bladder show none. D,E: Axial T2-weighted spin-echo images from individual Group 1 and Group
2 rats, respectively. D: Marked bowel wall signal hyperintensity presumably due to inflammation (arrows), while (E) shows rela-
tively lower bowel wall signal intensity presumably due to fibrosis (arrows; even though there is histologic evidence of extensive
superimposed inflammation in this animal). The bowel wall in (E) has a layered appearance, with the outer portion of the bowel
wall (corresponding to muscularis propria) having relatively lower signal intensity compared to the inner portion. B5urinary
bladder.
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endoscopic therapies.8,9,11,12 Unfortunately, currently avail-
able imaging methods have limitations when trying to deter-
mine if areas of intestinal narrowing in CD contain fibrosis.
In a study by Adler et al,10 histologic fibrosis and inflamma-
tion were found to be correlated in intestinal strictures, and
"strictures on CT enterography (CTE) with the most disease
activity also had the most fibrosis on histology."
Of regularly used radiologic modalities, it is conceiva-
ble that magnetic resonance imaging (MRI) has the best
chance of detecting fibrosis in intestinal strictures in CD
patients. This is because this imaging modality permits
image creation based on numerous forms of contrast.13
While image contrast can be obtained using exogenous
intravenously administered gadolinium chelates, these con-
trast agents have drawbacks, including added cost to the
examination, risk of nephrogenic systemic fibrosis (NSF) in
patients with substantial (individuals with estimated glomer-
ular filtration rate <30 mL/min/1.73 m2, in particular)
renal dysfunction, and low risk of allergic-like reaction.14
Numerous MRI techniques are also available that provide
image contrast based on endogenous tissue characteristics
(eg, T1 relaxation, T2 relaxation, diffusion of water). A
review of the literature shows a small number of studies
describing the use of magnetization transfer MRI (MT-
MRI) and T2-weighted imaging for detection of bowel wall
fibrosis.15–19 However, there is a paucity of data comparing
these two different MRI techniques, including in the setting
of superimposed intestinal inflammation.
The purpose of our study was to compare the diag-
nostic performances of two different quantitative noncon-
trast MRI techniques, MT-MRI and T2-weighted signal
intensity (T2WSI) ratios, for detecting bowel wall fibrosis
in the setting of superimposed intestinal inflammation in a
CD animal model.
Materials and Methods
All rodent procedures were approved by our institutional Commit-
tee on the Use and Care of Animals and complied with the
National Institutes of Health Guide for Care and Use of Laboratory
Animals. Ten Lewis rats ("Group 1") received a single trinitroben-
zenesulfonic acid (TNBS)-ethanol enema (15 mg TNBS in 50%
ethanol) in order to induce inflammation and narrowing of the
distal colon and rectum. An additional 10 rats ("Group 2")
received five weekly enemas of TNBS-ethanol with escalating
TNBS doses (15 to 60 mg) in order to induce both inflammation
and fibrosis as well as narrowing of the distal colon and rectum
(thus, mimicking human CD), as it is well established that recur-
rent TNBS-ethanol enemas cause multiple cycles of colitis and
bowel wall healing that culminate in transmural intestinal fibro-
sis.20 Each enema delivered 250 lL of TNBS-ethanol 7 cm into
the rat colon using a pediatric (5 French) feeding tube. One ani-
mal in Group 2 died prior to imaging.
Imaging of the colon was performed in each animal cohort 2
days after the final enema using a 2.0-T clear-bore MR system
(Varian Unity/Inova, Palo Alto, CA) equipped with actively
shielded Acustar gradients (Fig. 1). Images were acquired using a
50 mm diameter, 80 mm length Alderman-Grant slotted cylinder
RF probe, and imaging was performed under general anesthesia
using isoflurane. After localizer imaging, MT-MRI was performed
using a gradient recalled-echo pulse sequence (TR5 200; TE5 3
msec; flip angle5 20 degrees; slice thickness5 2 mm; in-plane res-
olution5 0.33 3 0.33 mm; number of signal averages5 4; MT
pulse5 15 msec Gaussian [1200 flip] applied to each phase
encode at 5 kHz and 10 kHz off-resonance). Axial imaging was
performed through the rat pelvis and mid-abdomen in order to
image the rectum and distal colon. Both 5 and 10 kHz off-
resonance pulses were applied in order to generate the MT effect.
T2-weighted spin-echo imaging was next performed using similar
anatomic coverage (TR5 2000 msec; TE5 80 msec; slice
thickness5 2 mm; in-plane resolution5 0.25 3 0.25 mm; num-
ber of signal averages5 2).
TABLE 1. Histologic Inflammation and Fibrosis Scoring Systems.
Scoring system Description
Acute Inflammation Score
0 (none) No inflammation
1 (mild) Few neutrophils in mucosa/submucosa; no transmural injury or necrosis
2 (moderate) Many neutrophils in mucosa/submucosa; no transmural injury or necrosis
3 (severe) Neutrophils in all layers of the bowel wall; transmural injury or necrosis
Fibrosis Score
0 (none) No architectural distortion; no abnormal Masson’s trichrome staining
1 (mild) No architectural distortion; abnormal Masson’s trichrome staining in <50% histopathologic layers
2 (moderate) No architectural distortion; abnormal Masson’s trichrome staining in >50% histopathologic layers
3 (severe) Architectural distortion of the muscularis propria; abnormal
Masson’s trichrome staining in all histopathologic layers
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For each animal, MT ratios (MTR) were calculated using
both 5 and 10 kHz off-resonance data in the area of greatest colo-
nic thickening, as determined by a single author (J.R.D., 5 years of
experience postfellowship training). MTR was calculated using the
following equation:
MTR %ð Þ5 12 Msat image =M0 image½ ð Þ3 100
where "Msat image" is bowel wall signal intensity on images col-
lected with 5 (or 10 kHz) off-resonance RF saturation, and "M0
image" is bowel wall signal intensity on images without RF satura-
tion. MTR was also calculated for paraspinous muscle on the same
image that was used to assess the bowel, again using both 5 and
10 kHz off-resonance data. Entire bowel wall regions-of-interest
(ROIs) were employed to measure MT signal intensities using Mat-
Lab (Natick, MA).
T2WSI ratio was calculated for each animal in the area of
greatest colonic wall thickening by measuring bowel wall signal
intensity as well as paraspinous muscle signal intensity on the same
image, and then dividing these two measurements. As with MTR,
entire bowel wall ROIs placed using MatLab were employed to
measure signal intensities.
Animals were euthanized immediately after MRI using
inhaled carbon dioxide, and colons were resected in order to obtain
tissue for histopathologic evaluation. Following tissue fixation in
formalin and after standard tissue processing, full-thickness tissue
specimens from the distal colon and rectum were embedded in
paraffin. Representative 5 lm sections were then mounted on glass
slides and stained using hematoxylin and eosin (Histology and
Immunoperoxidase Laboratory, University of Michigan) as well as
Masson’s trichrome (McClinchey Histology Lab, Inc.). Colorectal
histologic specimens were scored in a blinded fashion by a
fellowship-trained gastrointestinal pathologist (D.S.M., 3 years of
experience postfellowship training) for histologic inflammation and
fibrosis using previously described scoring systems (both inflamma-
tion and fibrosis were scored 0–3) (Table 1).21–23
Bowel wall collagen protein was isolated from full-thickness
colorectal tissue, as previously described.23 Collagen was quanti-
tated by western blotting using a rabbit-polyclonal antibody against
collagen type I (Rockland, Gilbertsville, PA) and normalized to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, an enzyme
required for glycolysis and the breakdown of glucose).23 Autoradio-
graphs were digitally scanned and quantified using ImageJ analysis
software.24
Statistical Analysis
Continuous data were summarized using means and standard devi-
ations and box-and-whisker plots were created. Categorical data
FIGURE 2: A,B: Bowel wall histologic images (mucosal surface oriented downward) from a Group 1 rat demonstrate extensive
acute inflammation, hemorrhage, and necrosis. The submucosa is expanded, and no abnormal fibrosis is present. C,D: Bowel wall
histologic images (mucosal surface oriented upward) from a Group 2 rat demonstrate mural thickening with inflammation, trans-
mural fibrosis (blue stain), and mucosal ulceration (arrows).
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were summarized using counts and percentages. Pearson correlation
(r) was used to explore the relationship between continuous varia-
bles, while Spearman correlation (q) was used to explore the rela-
tionship between continuous and discrete variables. Bowel wall
MTR, bowel wall MTR normalized to paraspinous muscle MTR
("normalized MTR"), and T2WSI ratios were compared between
animal groups using Student’s t-test. Receiver operating characteris-
tic (ROC) curve analyses were performed to compare diagnostic
performances. Sensitivity and specificity for detection of bowel wall
fibrosis were calculated as were positive likelihood ratios. In addi-
tion, the diagnostic performance of a novel parameter—bowel wall
T2WSI ratio divided by normalized MTR using a 10 kHz off-
resonance pulse ("T2WSI/MTR")—was also evaluated.
P< 0.05 was considered statistically significant. Statistical
analyses were performed using GraphPad Prism 6 (GraphPad Soft-
ware, La Jolla, CA).
Results
Bowel Wall Histologic Scoring and Collagen
Quantification
Histologic scoring of colons showed similar amounts of
bowel wall inflammation in each animal group (3.0 for
Group 1 vs. 3.0 for Group 2; P5 1.0). Group 1 had a
mean fibrosis score of 0.0 compared to 2.78 for Group 2
(P< 0.0001) (Fig. 2).
Group 1 had a bowel wall mean collagen content of
0.106 0.06 compared to 1.056 0.46 for Group 2
(P5 0.0002). There was a significant positive correlation
between bowel wall collagen content and histologic fibrosis
score, with q5 0.76 (P5 0.0002) (Fig. 3).
Bowel Wall MTR and Normalized MTR
At 5 kHz off-resonance, bowel wall mean MTR for Group
1 was 34.76 5.2% compared to 40.36 3.6% for Group 2
(P5 0.015). Mean normalized MTR was 0.536 0.08 for
Group 1 and 0.646 0.07 for Group 2 (P5 0.003).
At 10 kHz off resonance, bowel wall mean MTR for
Group 1 was 24.86 3.1% compared 30.36 3.2% for Group
2 (P5 0.001). Mean normalized MTR was 0.456 0.05 for
Group 1 and 0.586 0.08 for Group 2 (P5 0.0003) (Fig. 4).
There was only weak-to-moderate linear correlation
between bowel wall collagen content and normalized MTR
using a 10 kHz off-resonance pulse (r5 0.35; P5 0.15).
Scatterplot inspection showed that the relationship between
collagen and MTR may not be linear, although MTR
increased with increasing collagen up to a certain amount.
At the highest levels of bowel wall collagen, MTR was
noted to decrease. Similar patterns were observed for both
FIGURE 3: Scatterplot with fit line (solid; 95% confidence inter-
val shown as dotted lines) displaying the relationship between
bowel wall collagen content based on the western blot method
and histologic fibrosis score (q50.76; P50.0002).
FIGURE 4: A: Box-and-whisker plot showing bowel wall MTRs
using 10 kHz off-resonance pulse for animals with inflamed
(Group 1) and mixed inflammatory and fibrotic (Group 2) bowel
segments (P50.001). B: Box-and-whisker plot showing bowel
wall MTR normalized to paraspinous muscle MTR using 10 kHz
off-resonance pulse for animals with inflamed (Group 1) and
mixed inflammatory and fibrotic (Group 2) bowel segments
(P50.0003).
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nonnormalized and normalized 5 and 10 kHz off-resonance
data (Fig. 5).
T2WSI Ratio
Bowel wall mean T2WSI ratio was 5.326 0.98 for Group 1
and 3.016 0.66 for Group 2 (P< 0.0001) (Fig. 6). There
were moderate-strong negative linear correlations between
T2WSI ratio and normalized MTR (r5 –0.63; P5 0.004)
and between T2WSI ratio and bowel wall collagen content
(r5 –0.7; P5 0.0009) (Fig. 7).
ROC Curve Analyses
Bowel wall MTRs demonstrated ROC areas-under-the-
curve (AUC) of 0.81 at 5 kHz and 0.88 at 10 kHz off-
resonance, respectively, for discriminating purely inflamed
from mixed inflammatory and fibrotic colon. Normalized
MTRs demonstrated ROC AUC of 0.88 at 5 kHz and
0.89 at kHz off-resonance, respectively. T2WSI ratios dem-
onstrated the best diagnostic performance for discrimina-
tion of Group 2 from Group 1 animals, with an ROC
AUC of 0.97 (Fig. 8).
MTR, normalized MTR, and T2WSI ratio sensitiv-
ities, specificities, and positive likelihood ratios for discrimi-
nating bowel segments with both inflammation and fibrosis
(Group 2) from those with only inflammation (Group 1)
were calculated and are presented in Table 2.
The diagnostic performance of a novel parameter—
bowel wall T2WSI ratio divided by normalized MTR using
a 10 kHz off-resonance pulse ("T2WSI/MTR")—was also
assessed (Fig. 9). The mean of this novel parameter was
12.066 2.70 for Group 1 and 5.226 1.29 for Group 2
(P< 0.0001). ROC AUC for this novel parameter for
detecting bowel wall fibrosis was 0.98. Parameter sensitivity,
specificity, and positive likelihood ratio are presented in
Table 2.
Discussion
MRI using a magnetization transfer technique (MT-MRI)
allows image contrast to be generated based on the interac-
tions between the protons of free water and those of large
immobilized macromolecules, such as collagen.16,25 Image
contrast due to the presence of collagen at MT-MRI is most
likely because of exchange of protons of hydroxyl and
amino groups and water and related exchange of longitudi-
nal magnetization.26 It is has been theorized that the pres-
ence of bowel wall fibrosis should cause increased MTR.16
This imaging technique, while not used commonly in
FIGURE 5: A: Scatterplot showing the relationship between
bowel wall collagen vs. MTR using a 10 kHz off-resonance
pulse. B: Scatterplot showing the relationship between bowel
wall collagen vs. normalized MTR using a 10 kHz off-resonance
pulse shows a similar pattern.
FIGURE 6: Box-and-whisker plot showing bowel wall T2-
weighted signal intensity (T2WSI) normalized to paraspinous
muscle signal intensity for animals with inflamed (Group 1) and
mixed inflammatory and fibrotic (Group 2) strictures
(P<0.0001).
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routine clinical MRI in the abdomen or pelvis, is available
on most clinical MRI scanners, and imaging can be per-
formed using a fast imaging techniques, such as a breath-
hold gradient recalled-echo pulse sequence. Our results con-
firm those previously published by Adler et al,16 who found
that MT-MRI is "sensitive to bowel wall fibrosis as occurs
in Crohn’s strictures." In their study, the bowel wall MTR
of rats with fibrosis was higher than the MTR of control
animals and animals with bowel wall inflammation but no
fibrosis.
Our study corroborates the results of Adler et al16
using an entirely different CD animal model. The rodent
model used in the Adler et al16 investigation used subserosal
injections of peptidoglycan-polysaccharide to cause inflam-
mation of the cecum and eventual intestinal fibrosis,
whereas our rodent model used TNBS-ethanol enemas to
cause inflammation and eventual fibrosis of the distal colon
and rectum.27,28 When comparing bowel wall MTR in ani-
mals with inflammation only to animals with mixed inflam-
mation and fibrosis, we were able to show similar significant
results using both 5 kHz and 10 KHz off-resonance pulses.
Upon normalizing bowel wall MTR to skeletal muscle
MTR, even better discrimination between animal groups
was able to be achieved with even greater statistical
significance.
Bowel wall T2WSI ratios were also significantly differ-
ent between animals with purely inflammatory lesions and
animals with mixed inflammatory and fibrotic lesions.
Purely inflammatory animals showed significantly higher
T2WSI ratios than animals with mixed lesions. This is pre-
sumably because the extensive bowel wall fibrosis in the lat-
ter animal group, which was confirmed by bowel wall
histologic evaluation and collagen quantification, causes T2
shortening and associated signal loss. Fibrosis is well known
to lower T2-weighted signal intensity, although there is little
known about how fibrosis affects bowel wall signal intensity
in the setting of superimposed inflammation. These results
suggest that mixed strictures in human CD may well have
lower T2-weighted signal intensities when normalized to
muscle signal intensity than purely inflamed strictures,
although the diagnostic performance of this ratio has yet to
FIGURE 7: A: Scatterplot showing the relationship between
bowel wall normalized MTR at 10 kHz off-resonance vs. T2-
weighted signal intensity (T2WSI) normalized to paraspinous
muscle (r5 –0.63; P50.004). Animals in Groups 1 (bowel wall
inflammation only) and 2 (mixed inflammation and fibrosis) clus-
ter into two distinct groups. A single Group 1 animal is present
in the Group 2 cluster. B: Scatterplot showing the relationship
between bowel wall collagen content vs. T2-weighted signal
intensity (T2WSI) normalized to paraspinous muscle (r5 –0.70;
P50.0009). Increased collagen is moderate-to-strongly corre-
lated with decreased bowel wall T2-weighted signal intensity.
FIGURE 8: ROC curve for discrimination of mixed inflammatory
and fibrotic bowel segments (Group 2 animals) from purely
inflamed bowel segments (Group 1 animals) using bowel wall
T2-weighted signal intensity (T2WSI) ratios. AUC is 0.97, con-
sistent with excellent diagnostic performance.
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be established in clinical practice. Interestingly, the colons of
several fibrotic animals also showed a clear layered appear-
ance, with the outer portion of the bowel wall having rela-
tively lower signal intensity than the inner portion.
Additional study is needed to establish the significance of
this observation, as evaluation of the bowel wall for a lay-
ered appearance was not a formally assessed outcome.
Based on bowel wall collagen quantification using the
western blot method, we demonstrated that as collagen
increased, T2WSI ratios decreased. Scatterplot inspection
showed that the loss of bowel wall T2-weighted signal inten-
sity occurred at relatively low collagen concentrations and
then plateaued (perhaps a "floor effect"). Further research is
needed to determine if this observation is reproducible. Cor-
relation of MTR with bowel wall collagen showed that
MTR increased with increasing collagen to a certain level.
However, a decrease in MTR was seen in animals with the
greatest amounts of collagen. This finding is of uncertain
origin, and more research is needed to determine if this
observation is correct.
When comparing the diagnostic performances of
bowel wall MTR using 5 and 10 kHz off-resonance pulses,
normalized MTR using 5 and 10 kHz off-resonance pulses,
and T2W SI ratios, there are several interesting observations.
First, three of four MT-MRI techniques, including bowel
wall MTR using a 10 kHz off-resonance pulse as well as
normalized MTR using 5 and 10 kHz off-resonance pulses,
have similar diagnostic performances. Second, bowel wall
T2WSI ratios, which can be very easily calculated on routine
clinical T2-weighted images, seem to have better diagnostic
performance than MTR, with an ROC AUC of 0.97. Vis-
ual inspection of our data using a scatterplot of normalized
MTR (using a 10 kHz off-resonance pulse) vs. T2WSI ratios
shows that 18 of our 19 animals that survived to imaging
cluster into two very distinct cohorts that make sense based
on histology and MRI physics. Group 1 animals, those with
purely inflammatory lesions, have high bowel wall T2WSI
ratios and low normalized MTR, whereas Group 2 animals,
those with mixed inflammatory and fibrotic lesions, have
relatively low T2WSI ratios and relatively high normalized
MTR.
Based on this observed clustering, a novel parameter—
T2WSI ratio divided by normalized MTR using a 10 kHz
off-resonance pulse ("T2WSI/MTR")—was devised. This
parameter actually demonstrated better diagnostic perform-
ance than MT-MRI or T2WSI ratios alone, and it allowed
the best discrimination between fibrotic (Group 2) and non-
fibrotic (Group 1) animals. In clinical practice when imag-
ing actual human CD patients, we propose that high-
TABLE 2. Sensitivites, Specificities, and Positive Liklihood Values of Magnetization Transfer Ratio (MTR), Normal-
ized MTR, and T2-Weighted Signal Intensity (T2WSI) Ratios for Discriminating Mixed Inflamed and Fibrotic From
Purely Inflamed Bowel Segments
Noncontrast MRI technique Sensitivity Specificity Positive liklihood ratio Cutoff value
MTR - 5 kHz off-resonance 67% 90% 6.67 >40.4
MTR - 10 kHz off-resonance 78% 90% 7.78 >27.6
Normalized MTR (5 kHz) 67% 90% 6.67 >0.63
Normalized (10 kHz) 67% 90% 6.67 >0.52
T2WSI Ratio 89% 90% 8.89 <3.93
T2W/MTR parameter 100% 90% 10.0 <8.65
MTR5magnetization transfer ratio; kHz5 kilohertz; T2WSI5T2-weighted signal intensity; T2W/MTR5T2-weighted signal inten-
sity divided by normalized magnetization transfer ratio using a 10 kHz off-resonance pulse.
FIGURE 9: Box-and-whisker plot showing the novel parameter:
bowel wall T2-weighted signal intensity (T2WSI) ratio divided by
normalized MTR (using a 10 kHz off-resonance pulse), or "T2W/
MTR," for inflamed (Group 1) and mixed inflammatory and
fibrotic (Group 2) colon (P<0.0001). Dots represent statistical
outliers (greater than 1.5 interquartile ranges below first quar-
tile or above third quartile).
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quality, targeted T2-weighted imaging and MT-MRI be per-
formed through any area of disease demonstrating bowel
wall thickening, luminal narrowing, and upstream dilatation
in order to optimize both signal-to-noise ratio and spatial
resolution as well as facilitate ROI placement. These find-
ings, together, suggest the presence of an obstructing stric-
ture that would benefit from bowel wall tissue
characterization (ie, is there fibrosis?). Based on the known
distribution of CD, these strictures are most likely to
involve the distal or terminal ileum, although there is no
reason why strictures involving other portions of the intes-
tine cannot be characterized by MRI. While the colon is
commonly filled with fecal material (especially upstream to
an obstructing stricture), portions causing bowel obstruction
(with associated substantial wall thickening and luminal nar-
rowing) are generally well visualized by MRI and can prob-
ably be characterized without a formal pre-MRI colon
cleansing regimen.
Our study has a few limitations to be acknowledged.
First, imaging was performed on a CD animal model and
not human CD patients. While a particular advantage of
our animal model is that it allows transmural histologic
evaluation of the colon immediately after MRI, these non-
contrast MRI techniques must be further assessed in vivo in
human CD patients with intestinal strictures just prior to
surgery in order to obtain one-to-one MRI-histopathology
correlation. Second, further investigations are required to
determine the true sensitivities and specificities of these
bowel wall imaging techniques in humans. We do not know
if one technique, both techniques combined (eg, novel
T2WSI/MTR parameter), or neither technique is sensitive
for detecting small amounts of bowel wall fibrosis or pro-
gression of bowel wall fibrosis over time. Also, it is very
possible that the relationships between fibrosis/collagen and
both MTR and T2WSI ratios are complex and nonlinear. It
is reassuring that a recent study by Pazahr et al29 performed
to assess the feasibility of MT-MRI in human CD patients
found that MTR was significantly increased in bowel wall
segments with fibrotic scarring.
Finally, numerous additional studies, which will likely
be in vitro, in vivo in animals, as well as in vivo in
humans, are needed to completely optimize pulse sequences
used to obtain MT-MRI and T2WSI data in order to maxi-
mize the clinical utility of these techniques. For example,
MT imaging can be performed in conjunction with several
routinely employed clinical pulse sequences (eg, gradient
recalled-echo vs. balanced steady-state free precession) and
using a wide range of off-resonance pulses (eg, 5 vs.
10 kHz); we do not know which pulse sequence or off-
resonance frequency will offer the greatest sensitivity and
specificity for detecting bowel wall fibrosis. T2-weighted
imaging of the bowel also can be performed using a variety
of routine clinical pulse sequences (eg, single-shot fast spin-
echo vs. fast spin-echo) with many associated parameters
that require optimization as well.
In conclusion, both MT-MRI and T2WSI ratios, two
different quantitative noncontrast MRI techniques that rely
on endogenous tissue contrast, allow detection of bowel wall
fibrosis in the setting of superimposed inflammation in a
CD animal model. Upon direct comparison, our data sug-
gest that T2WSI ratios offer better diagnostic performance
for discriminating inflamed from mixed inflammatory and
fibrotic strictures than MT-MRI based on ROC curve analy-
sis. A novel parameter—bowel wall T2WSI ratio divided by
normalized MTR—also offers excellent diagnostic perform-
ance and may be better than MT-MRI or T2WSI ratios
alone. Additional studies are necessary to further optimize
these MRI techniques for the detection of bowel wall fibro-
sis and discrimination of fibrosis from inflammation as well
as to assess their individual and combined clinical utilities
in humans with stricturing CD.
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